FDA Permanently Debars Five Individuals in One Day

The FDA issued final orders permanently debarring five individuals from submitting or assisting with drug applications on April 6, 2026. Those debarred include Bernardo Garmendia, John Warrington Kosolcharoen, Miguel Angel Montalvo Villa, Maria Anzures-Camarena, and Matthew Teltser. The orders prevent them from participating in any drug application submissions under the Federal Food, Drug, and Cosmetic Act.

The simultaneous debarments of five individuals on a single day suggest a coordinated enforcement action likely tied to a fraud investigation involving drug application submissions.

Pharmaceutical companies and contract research organizations should verify that their consultants and contractors have not been debarred, as engaging debarred individuals in drug approval processes carries serious legal consequences.